Last edition
News about Market
IMG Pharma to Acquire Matsumoto Pharmaceutical
IMG Pharma signs a definitive agreement to acquire Matsumoto Pharmaceutical, combining biopharmaceutical innovation with manufacturing and OTC capabilities, forming a multi-layered product capability structure.
Market | 28/04/2026 | By News Bureau | 153
Xcovery Partners with EVERSANA to Launch Ensacove in US
Xcovery Holdings Inc. partners with EVERSANA to commercialize Ensacove in the U.S., leveraging end-to-end services including market access, medical and commercial support to expand lung cancer treatment availability.
Market | 28/04/2026 | By News Bureau | 215
Eli Lilly and Company to Acquire Ajax Therapeutics to Expand Blood Cancer Pipeline
Eli Lilly and Company to acquire Ajax Therapeutics, advancing its blood cancer pipeline with AJ1-11095, a Phase 1 JAK2 inhibitor targeting myelofibrosis and polycythemia vera, with potential for improved disease control.
Market | 28/04/2026 | By News Bureau | 174
Sun Pharmaceutical Industries Signs Definitive Agreement to Acquire Organon
Sun Pharmaceutical Industries signs a definitive agreement to acquire Organon for USD 14 per share, valuing the deal at USD 11.75B EV. The merger aims to leverage complementary portfolios and global scale for long-term growth.
Market | 27/04/2026 | By News Bureau | 315
ImmunoForge Unveils LMT15 Platform to Transform CNS Drug Delivery
The clinical-stage biotech firm ImmunoForge is advancing its next-generation blood-brain barrier shuttle technology, combining enhanced brain permeability with long-acting formulations to accelerate therapies for CNS and rare diseases.
Market | 24/04/2026 | By News Bureau | 178
Atrium Therapeutics receives a USD 15 million milestone payment from Bristol Myers Squibb under a global collaboration to develop innovative RNA-based therapies for cardiovascular diseases.
Market | 24/04/2026 | By News Bureau | 153
Nektar Therapeutics Closes USD 373.8 Million Public Offering
Nektar Therapeutics completes USD 373.8 million public offering, including full exercise of underwriters’ option to purchase additional shares.
Market | 24/04/2026 | By News Bureau | 170
Andelyn Biosciences and ENCell Forge Global Manufacturing Alliance
Andelyn Biosciences and ENCell partner to build a cross-continental manufacturing network, enabling faster development and global delivery of advanced gene therapies.
Market | 23/04/2026 | By News Bureau | 176
Amneal Pharmaceuticals to Acquire Kashiv BioSciences to Create Integrated Global Biosimilar Platform
Amneal Pharmaceuticals to buy Kashiv BioSciences, accelerating biosimilar pipeline and strengthening US market position for affordable medicines.
Market | 23/04/2026 | By News Bureau | 195
Zyax Chem Buys 26 Percent Stake in Gaymed Labs
Zyax Chem acquires 26 percent stake in Gaymed Labs, securing board representation and boosting expansion in the ophthalmic segment.
Market | 22/04/2026 | By News Bureau | 131
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy